Summary
Agilent Technologies, Inc. (A) filed this Current Report on Form 8-K on July 18, 2018, to provide updated segment information following a reorganization of its microfluidics business. This business unit, previously part of the Life Science and Applied Markets segment, has been integrated into the Diagnostics and Genomics operating segment. This filing is primarily informational, furnishing selected segment data to reflect the new divisional structure and should be read in conjunction with Agilent's other SEC filings, including its Form 10-K.
Key Highlights
- 1Agilent Technologies is reorganizing its microfluidics business unit.
- 2The microfluidics business will move from the Life Science and Applied Markets segment to the Diagnostics and Genomics operating segment.
- 3This 8-K is being furnished to provide updated segment information reflecting the reorganization.
- 4Selected historical segment financial information (quarters and fiscal years ending 2016 and 2017) is being provided via Exhibit 99.1.
- 5The information furnished in this report is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.
- 6Investors should review Exhibit 99.1 for the specific segment data reflecting the organizational change.
Frequently Asked Questions
The main purpose of this 8-K filing is to inform investors about a reorganization within Agilent Technologies. Specifically, the microfluidics business has been moved to a new division within the Diagnostics and Genomics operating segment, and the company is providing updated segment information to reflect this change.
The microfluidics business, previously under the Life Science and Applied Markets segment, is now part of the Diagnostics and Genomics operating segment. This filing provides selected historical segment data to illustrate the impact of this structural change.
The selected segment information reflecting the reorganization is provided in Exhibit 99.1, which is attached to this Current Report on Form 8-K.
No, the information provided in this report, including Exhibit 99.1, is being 'furnished' and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings. This means it generally does not carry the same legal liabilities as 'filed' information.